Research from Kanazawa University on 8,766 older adults using MRI scans revealed a 3 percent reduction in brain white matter ...

The researchers analyzed the genomes of 3,962 Alzheimer's disease patients aged 65 to 85 and 4,074 seniors with normal cognitive function, both groups of which were registered in a biobank.

This research suggests that early menopause may itself be a direct risk factor for cognitive decline, even when depression ...

TOKYO – Japan is expected to lower the price of lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co.

A Japanese research organization revealed on Tuesday that the concluding stage of a clinical trial investigating a Parkinson’s medication as a possible therapy for familial Alzheimer’s disease ...

A recent study of patients who developed bipolar disorder or depression later in life revealed that half had high ...

Alzheimer’s research mostly includes white participants. ... and information for caregivers. Information is available in Chinese, Japanese, Korean, and Vietnamese languages.

FUKUOKA—Testosterone, a sex hormone produced primarily in male testes, could be the reason why men are less likely than women to develop Alzheimer’s disease, researchers with Kyushu University ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment option after Eisai and Biogen's Leqembi ...

Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for the future.

Cats vs dogs: Japan research sheds light on which pet betters health, lowers dementia risk Learning piano as senior aides brain plasticity, can help block dementia: Japan expert Up to 4 in 10 ...